Literature DB >> 1764353

The dermatosis of kwashiorkor in young children.

M C Latham1.   

Abstract

A characteristic dermatosis is often seen in young children suffering from kwashiorkor, one of the severe forms of protein-energy malnutrition (PEM). The skin lesions usually first occur in areas subject to friction or pressure, for example the groin, behind the knees, on the buttocks, and at the elbows; in advanced cases, the dermatosis may be almost anywhere on the body--trunk, limbs, or head. Darkly pigmented patches form, and these may peel or desquamate, rather like old, sun-baked blistered paint. This has led to the terms "peeling paint" or "flaky paint" dermatosis. Underneath these flakes are atrophic depigmented areas that may resemble a healing burn. This dermatosis does not occur in children with nutritional marasmus, the other life-threatening form of PEM. Kwashiorkor may be diagnosed and the condition be serious without any dermatosis being present. However, when "flaky paint" dermatosis is seen in a malnourished child with edema, it is pathognomonic of the disease kwashiorkor.

Entities:  

Mesh:

Year:  1991        PMID: 1764353

Source DB:  PubMed          Journal:  Semin Dermatol        ISSN: 0278-145X


  3 in total

1.  Re-appraisal of current theories for the development and loss of epidermal pigmentation in hominins and modern humans.

Authors:  Peter M Elias; Mary L Williams
Journal:  J Hum Evol       Date:  2013-03-09       Impact factor: 3.895

2.  [Infant with generalized edema and a skin rash].

Authors:  Pirabakaran Sivanesan; Thulasi Weerasinghe; Kavindra Nanayakkara; Sriyani Samaraweera; Jayamini Seneviratne; Peter Elsner
Journal:  Hautarzt       Date:  2021-07-30       Impact factor: 0.751

3.  The role of albumin and the extracellular matrix on the pathophysiology of oedema formation in severe malnutrition.

Authors:  Gerard Bryan Gonzales; James M Njunge; Bonface M Gichuki; Bijun Wen; Moses Ngari; Isabel Potani; Johnstone Thitiri; Debby Laukens; Wieger Voskuijl; Robert Bandsma; Jill Vanmassenhove; James A Berkley
Journal:  EBioMedicine       Date:  2022-04-07       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.